Showing 6,792 results

Filters Content type: News, Editors' picks Country: United States
Cardiovascular disease

Heart attack rates are declining, but not in people with HIV

News
15 February 2022
Epidemiology

Overall lifetime risk of being diagnosed with HIV in the US decreases by 11%, but stark racial and geographical disparities persist

News
15 February 2022
Activism & civil society

What Makes an Activist?

Editor's pick
POZ
15 February 2022
Transgender people

Trade-Off for Trans Women Between Hormones and Heart Risk

Editor's pick
POZ
15 February 2022
Coronavirus

Booster vaccine doses protect people with HIV against severe COVID-19

News
14 February 2022
Vaccinations & immunisations

New Yorkers With HIV Are Less Likely to Be Vaccinated Against COVID-19

Editor's pick
POZ
14 February 2022
Injectable & long-acting PrEP

Members of Congress ask CDC to cut cost of new HIV prevention drug

Editor's pick
The Hill
14 February 2022
People who inject drugs

HIV incidence rising steeply among people who inject drugs in Tijuana

Editor's pick
EurekAlert
14 February 2022
PrEP programmes & uptake

Community-led trans-affirming care shown to improve PrEP uptake in trans communities

News
10 February 2022
Economic & social inequality

HIV diagnoses among Black adults highest in US communities with more social vulnerabilities

Editor's pick
Healio
7 February 2022
Improving HIV care

Does your patient living with HIV need advice, empathy, or something different?

News
4 February 2022
PrEP policies & guidelines

When you're charged a PrEP copay you shouldn't owe

Editor's pick
Axios
2 February 2022
Harm reduction

It’s Time for Maine to Free Us From One-to-One Syringe Distribution

Editor's pick
Filter
2 February 2022
Treatment outcomes & life expectancy

Improvements in survival for people with HIV continue to be achieved

Editor's pick
CATIE
2 February 2022
People who inject drugs

Tele-harm reduction: a new approach in the US shows promise for people with HIV who inject drugs

News
2 February 2022
Injectable & long-acting HIV treatment

ViiV Healthcare announces US FDA approval of Cabenuva (cabotegravir, rilpivirine) for use every two months, expanding the label of the first and only complete long-acting HIV treatment

Editor's pick
ViiV press release
1 February 2022
HIV & criminal law

New Jersey Repeals Outdated HIV Crime Laws and Fights Stigma

Editor's pick
POZ
1 February 2022
People who inject drugs

The US must tackle racial disparities among people who inject drugs and expand syringe service programmes

News
26 January 2022
Harm reduction

More Syringe Exchanges Can Open in New Jersey, Thanks to a New Law

Editor's pick
POZ
25 January 2022
Pregnancy and vertical transmission

Updated US Guidelines: TAF In, Cabenuva Out for Pregnant People

Editor's pick
POZ
25 January 2022
Vaginal rings & topical PrEP

HIV Prevention Vaginal Ring Withdrawn From FDA Consideration

Editor's pick
Medscape (requires free registration)
25 January 2022
Vaccinations & immunisations

People living with HIV need tailored COVID-19 vaccination information

Editor's pick
EurekAlert
24 January 2022
PrEP policies & guidelines

US: State laws about prescribing may limit access to HIV pre-exposure prophylaxis

Editor's pick
EurekAlert
24 January 2022
The search for a cure

Deep dive into HIV’s hidden DNA finds that some people could eventually drop their drugs

News
24 January 2022